Meclizine Hydrochloride Tablet, Chewable
FDA Label NDC 71335-2177

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bryant Ranch Prepack for the product Meclizine Hydrochloride (NDC 71335-2177). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding drug facts, otc - purpose, uses, do not use in, ask a doctor before use if you have, ask a doctor or pharmacist before use if, when using this product, otc - pregnancy or breast feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

How Supplied

NDC: 71335-2177-1: 30 Tablets in a BOTTLE

NDC: 71335-2177-2: 20 Tablets in a BOTTLE

NDC: 71335-2177-3: 25 Tablets in a BOTTLE

NDC: 71335-2177-4: 40 Tablets in a BOTTLE

NDC: 71335-2177-5: 60 Tablets in a BOTTLE

NDC: 71335-2177-6: 90 Tablets in a BOTTLE

NDC: 71335-2177-7: 8 Tablets in a BOTTLE

NDC: 71335-2177-8: 14 Tablets in a BOTTLE

NDC: 71335-2177-9: 10 Tablets in a BOTTLE

NDC: 71335-2177-0: 120 Tablets in a BOTTLE

Package Label.Principal Display Panel

Meclizine 25MG Chewable

Label (Lbl713352177)

Label (Lbl713352177)

* Please review the disclaimer below.